Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

被引:317
作者
Powles, T. [1 ]
Bellmunt, J. [2 ]
Comperat, E. [3 ]
De Santis, M. [4 ]
Huddart, R. [5 ]
Loriot, Y. [6 ,7 ]
Necchi, A. [8 ]
Valderrama, B. P. [9 ]
Ravaud, A. [10 ,11 ]
Shariat, S. F. [12 ]
Szabados, B. [1 ,13 ]
van der Heijden, M. S. [14 ]
Gillessen, S. [15 ]
机构
[1] Queen Mary Univ London, Barts Canc Ctr, Barts Hlth NHS Trust, London, England
[2] Harvard Med Sch, Beth Israel Deaconess Med Ctr, IMIM Lab, Boston, MA 02115 USA
[3] Hop Tenon, Assistance Publ Hop Paris, Paris, France
[4] Charite, Dept Urol, Berlin, Germany
[5] Royal Marsden Hosp, Inst Canc Res, London, England
[6] Univ Paris Saclay, Dept Med Oncol, Villejuif, France
[7] Gustave Roussy, Villejuif, France
[8] Univ Vita Salute San Raffaele, IRCCS San Raffaele Hosp, Dept Med Oncol, Milan, Italy
[9] Univ Hosp Virgen del Rocio, Seville, Spain
[10] Hop St Andre CHU, Bordeaux, France
[11] Bordeaux Univ Hosp, Dept Med Oncol, Bordeaux, France
[12] Med Univ Vienna, Vienna Gen Hosp, Dept Urol, Vienna, Austria
[13] Univ Coll London Hosp, Dept Urol, London, England
[14] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands
[15] EOC, Oncol Inst Southern Switzerland IOSI, Lugano, Switzerland
关键词
immune checkpoint inhibitors; fibroblast growth factor receptor inhibitors; antibody drug conjugates; bladder cancer; urothelial carcinoma; platinum-based chemotherapy; METASTATIC UROTHELIAL CARCINOMA; BACILLUS-CALMETTE-GUERIN; PHASE-III TRIAL; TRANSITIONAL-CELL CARCINOMA; COMBINED-MODALITY TREATMENT; RADICAL CYSTECTOMY; OPEN-LABEL; SINGLE-ARM; ADJUVANT CHEMOTHERAPY; PREDICTING RECURRENCE;
D O I
10.1016/j.annonc.2021.11.012
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:244 / 258
页数:15
相关论文
共 121 条
[1]   Troubling Outcomes From Population-level Analysis of Surgery for Upper Tract Urothelial Carcinoma [J].
Abouassaly, Robert ;
Alibhai, Shabbir M. H. ;
Shah, Nasir ;
Timilshina, Narhari ;
Fleshner, Neil ;
Finelli, Antonio .
UROLOGY, 2010, 76 (04) :895-901
[2]   Surgical intervention in patients with urothelial carcinoma of the bladder and lymph node metastasis [J].
Abufaraj, Mohammad ;
Al-Ani, Abdallah ;
AlQudah, Alex ;
Shariat, Shahrokh F. .
CURRENT OPINION IN UROLOGY, 2021, 31 (03) :220-225
[3]   Micropapillary Urothelial Carcinoma of the Bladder: A Systematic Review and Meta-analysis of Disease Characteristics and Treatment Outcomes [J].
Abufaraj, Mohammad ;
Foerster, Beat ;
Schernhammer, Eva ;
Moschini, Marco ;
Kimura, Shoji ;
Hassler, Melanie R. ;
Preston, Mark A. ;
Karakiewicz, Pierre I. ;
Remzi, Mesut ;
Shariat, Shahrokh F. .
EUROPEAN UROLOGY, 2019, 75 (04) :649-658
[4]   The Role of Surgery in Metastatic Bladder Cancer: A Systematic Review [J].
Abufaraj, Mohammad ;
Dalbagni, Guido ;
Daneshmand, Siamak ;
Horenblas, Simon ;
Kamat, Ashish M. ;
Kanzaki, Ryu ;
Zlotta, Alexandre R. ;
Shariat, Shahrokh F. .
EUROPEAN UROLOGY, 2018, 73 (04) :543-557
[5]   The impact of treatment modality on survival in patients with clinical node-positive bladder cancer: results from a multicenter collaboration [J].
Afferi, Luca ;
Zamboni, Stefania ;
Karnes, R. Jeffrey ;
Roghmann, Florian ;
Sargos, Paul ;
Montorsi, Francesco ;
Briganti, Alberto ;
Gallina, Andrea ;
Mattei, Agostino ;
Schulz, Gerald Bastian ;
Hendricksen, Kees ;
Voskuilen, Charlotte S. ;
Rink, Michael ;
Poyet, Cedric ;
De Cobelli, Ottavio ;
di Trapani, Ettore ;
Simeone, Claudio ;
Soligo, Matteo ;
Simone, Giuseppe ;
Tuderti, Gabriele ;
Alvarez-Maestro, Mario ;
Martinez-Pineiro, Luis ;
Aziz, Atiqullah ;
Shariat, Shahrokh F. ;
Abufaraj, Mohammad ;
Xylinas, Evanguelos ;
Moschini, Marco .
WORLD JOURNAL OF UROLOGY, 2021, 39 (02) :443-451
[6]   Pembrolizumab (P) combined with chemotherapy (C) vs C alone as first-line (1L) therapy for advanced urothelial carcinoma (UC): KEYNOTE-361 [J].
Alva, A. ;
Csoszi, T. ;
Ozguroglu, M. ;
Matsubara, N. ;
Geczi, L. ;
Cheng, S. Y-S. ;
Fradet, Y. ;
Oudard, S. ;
Vulsteke, C. ;
Morales Barrera, R. ;
Flechon, A. ;
Gunduz, S. ;
Loriot, Y. ;
Rodriguez-Vida, A. ;
Mamtani, R. ;
Yu, E. Y. ;
Nam, K. ;
Imai, K. ;
Moreno, B. H. ;
Powles, T. B. .
ANNALS OF ONCOLOGY, 2020, 31 :S1155-S1155
[7]   Combined Chemohyperthermia: 10-Year Single Center Experience in 160 Patients with Nonmuscle Invasive Bladder Cancer [J].
Arends, Tom J. H. ;
van der Heijden, Antoine G. ;
Witjes, J. Alfred .
JOURNAL OF UROLOGY, 2014, 192 (03) :708-713
[8]   Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma [J].
Bajorin, D. F. ;
Witjes, J. A. ;
Gschwend, J. E. ;
Schenker, M. ;
Valderrama, B. P. ;
Tomita, Y. ;
Bamias, A. ;
Lebret, T. ;
Shariat, S. F. ;
Park, S. H. ;
Ye, D. ;
Agerbaek, M. ;
Enting, D. ;
McDermott, R. ;
Gajate, P. ;
Peer, A. ;
Milowsky, M., I ;
Nosov, A. ;
Antonio Jr, J. N. ;
Tupikowski, K. ;
Toms, L. ;
Fischer, B. S. ;
Qureshi, A. ;
Collette, S. ;
Unsal-Kacmaz, K. ;
Broughton, E. ;
Zardavas, D. ;
Koon, H. B. ;
Galsky, M. D. .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (22) :2102-2114
[9]   Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study [J].
Balar, Arjun, V ;
Kamat, Ashish M. ;
Kulkarni, Girish S. ;
Uchio, Edward M. ;
Boormans, Joost L. ;
Roumiguie, Mathieu ;
Krieger, Laurence E. M. ;
Singer, Eric A. ;
Bajorin, Dean F. ;
Grivas, Petros ;
Seo, Ho Kyung ;
Nishiyama, Hiroyuki ;
Konety, Badrinath R. ;
Li, Haojie ;
Nam, Kijoeng ;
Kapadia, Ekta ;
Frenkl, Tara ;
de Wit, Ronald .
LANCET ONCOLOGY, 2021, 22 (07) :919-930
[10]   Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial [J].
Balar, Arjun V. ;
Galsky, Matthew D. ;
Rosenberg, Jonathan E. ;
Powles, Thomas ;
Petrylak, Daniel P. ;
Bellmunt, Joaquim ;
Loriot, Yohann ;
Necchi, Andrea ;
Hoffman-Censits, Jean ;
Perez-Gracia, Jose Luis ;
Dawson, Nancy A. ;
van der Heijden, Michiel S. ;
Dreicer, Robert ;
Srinivas, Sandy ;
Retz, Margitta M. ;
Joseph, Richard W. ;
Drakaki, Alexandra ;
Vaishampayan, Ulka N. ;
Sridhar, Srikala S. ;
Quinn, David I. ;
Duran, Ignacio ;
Shaffer, David R. ;
Eigl, Bernhard J. ;
Grivas, Petros D. ;
Yu, Evan Y. ;
Li, Shi ;
Kadel, Edward E., III ;
Boyd, Zachary ;
Bourgon, Richard ;
Hegde, Priti S. ;
Mariathasan, Sanjeev ;
Thastrom, AnnChristine ;
Abidoye, Oyewale O. ;
Fine, Gregg D. ;
Bajorin, Dean F. .
LANCET, 2017, 389 (10064) :67-76